1. NAACCR June 2010 The System Performance Initiative: A Pan-Canadian Approach 1

3. The International Landscape… 3 European Cancer Health Indicator Project Cancer System Quality Index (CSQI) 2009

4. 4 First System Performance Report (2009): Process for Indicator Selection 4

5. 5 First System Performance Report (2009) Thanks to the System Performance Steering Committee Dr. Ivo OlivottoBC Dr. Peter CraigheadAB Mr. Ivan OlfertSK Dr. Brent SchacterMB Ms. Helen AngusON Dr. Denis RoyQC Dr. Grlica BolesnikovNB Dr. Margaret FitchON 5

6. Examples of Indicator Selection Criteria Coverage of cancer control continuum Reflective of outcomes, not process alone Impact on total cancer population Measurable Available (combination of this and “stretch goals” for measurement) Known directionality…..

7. 7 Indicators First Report (2009) 7

8. An iterative process..... Over first year, no intention to build ‘targets.’ Goal was to develop a process of sharing that would generate hypotheses and begin to identify reporting priorities The Report will develop further as confidence in the process and quality of information increases……. Analysis 2009: We presented national data, provincial comparisons, and data trends over time We also reported on SES, Education and Urban/Rural status where possible 8

9. The System Performance Initiative – A First Year Report

10. Smoking Prevalence & Smoking Quit Attempts – Canada (CCHS) 10

11. Smoking Quit Attempts over time and by Age Group – Canada (CCHS)

12. A pan-Canadian approach……. Using the data Example: Overweight & Obesity

13. A pan-Canadian approach……. Using the data Example: Overweight & Obesity

14. 14 2010 – Second SP Report…… and beyond Winter 09-10 Feasibility Study for new indicators JanuaryData ask to provinces CurrentData analysis and refinement JulyEmbargoed release of “Overview” Report Jul – AugFeedback & Clarification SeptemberYear 2 Report published 2 subsequent drill-down reports expected (Fall 2010, Spring 2011) 14

15. 15 Pan-Canadian System Performance Working Group First conference call – November 2009 Dr. Susan O’ReillyBC Dr. Peter CraigheadAB Mr. Ivan OlfertSK Dr. Eric BowMB Ms. Katya DuvalkoON TBAQC Dr. Grlica BolesnikovNB Mr. Gordon WalshNS Dr. Dagny DryerPEI Ms. Sharon SmithNL 15

16. 16 And report on: 11 Proposed New Indicators 16 Guideline Concordance Indicators Other Adjuvant chemotherapy for fully resected Stage III colon cancer Removal & examination of 12 or more lymph nodes for colon cancer Adjuvant radiation therapy following breast conserving surgery for Stage I & II breast cancer Neoadjuvant radiation therapy for Stage II and III rectum cancer (Palliative) Site of Cancer Death Clinical Trial Participation Rates HPV Vaccination Rates (school-based programs) Systemic Therapy Utilization Rates Wait Times, FOBT to Colonoscopy Patient Reported Outcomes Adjuvant chemotherapy for fully resected Stage II & IIIA Non-Small Cell Lung Cancer

17. Thank you! The 2009 Report is available online at: www.cancerview.ca For more information, please contact: Mary Spayne, Director, System Performance mary.spayne@partnershipagainstcancer.ca